Literature DB >> 21931125

Nocturnal, every-other-day, online haemodiafiltration: an effective therapeutic alternative.

Francisco Maduell1, Marta Arias, Carlos E Durán, Manel Vera, Néstor Fontseré, Manel Azqueta, Nayra Rico, Nuria Pérez, Alexis Sentis, Montserrat Elena, Néstor Rodriguez, Carola Arcal, Eduardo Bergadá, Aleix Cases, Jose Luis Bedini, Josep M Campistol.   

Abstract

BACKGROUND: Longer and more frequent dialysis sessions have demonstrated excellent survival and clinical advantages, while online haemodiafiltration (OL-HDF) provides the most efficient form of dialysis treatment. The aim of this study was to evaluate the beneficial effects of a longer (nocturnal) and more frequent (every-other-day) dialysis schedule with OL-HDF at the same or the highest convective volume.
METHODS: This prospective, in-centre crossover study was carried out in 26 patients, 18 males and 8 females, 49.2±14 years old, on 4-5 h thrice-weekly post-dilution OL-HDF, switched to nocturnal every-other-day OL-HDF. Patient inclusion criteria consisted of stable patients with good vascular access and with good prospects for improved occupational, psychological and social rehabilitation. Patients were randomly assigned into two groups: Group A received the same convective volume as previously for 6 months followed by a higher convective volume for a further 6 months, while Group B received the same schedule in reverse order.
RESULTS: Nocturnal every-other-day OL-HDF was well tolerated and 56% of patients who were working during the baseline period continued to work throughout the study with practically no absenteeism. The convective volume was 26.7±2 L at baseline, 27.5±2 with the unchanged volume and 42.9±4 L with the higher volume. eKt/V increased from 1.75±0.4 to 3.37±0.9. Bicarbonate, blood urea nitrogen (BUN) and creatinine values decreased, while phosphate levels fell markedly with a 90% reduction in phosphate binders. Blood pressure and left ventricular hypertrophy (LVH) improved and the use of anti-hypertensive drugs decreased. In both groups, BUN, creatinine and β2-microglobulin reduction ratios improved. Different removal patterns were observed for myoglobin, prolactin and α1-acid glycoprotein.
CONCLUSIONS: Nocturnal every-other-day OL-HDF could be an excellent therapeutic alternative since good tolerance and occupational rehabilitation, marked improvement in dialysis dose, nutritional status, LVH, phosphate and hypertension control and a substantial reduction in drug requirements were observed. In this crossover study, different removal patterns of large solutes were identified.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21931125     DOI: 10.1093/ndt/gfr491

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

1.  Association between change in serum bicarbonate and change in thyroid hormone levels in patients receiving conventional or more frequent maintenance haemodialysis.

Authors:  Alessio Molfino; Gerald J Beck; Minwei Li; Joan C Lo; George A Kaysen
Journal:  Nephrology (Carlton)       Date:  2019-01       Impact factor: 2.506

Review 2.  Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico.

Authors:  Maria Eleni Roumelioti; Thomas Nolin; Mark L Unruh; Christos Argyropoulos
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

Review 3.  Nutritional Status in Nocturnal Hemodialysis Patients - A Systematic Review with Meta-Analysis.

Authors:  Karin J R Ipema; Simone Struijk; Annet van der Velden; Ralf Westerhuis; Cees P van der Schans; Carlo A J M Gaillard; Wim P Krijnen; Casper F M Franssen
Journal:  PLoS One       Date:  2016-06-20       Impact factor: 3.240

4.  Investigating the effects of 6 months extended duration, in-centre nocturnal versus conventional haemodialysis treatment: a non-randomised, controlled feasibility study.

Authors:  Darren R Churchward; Matthew P M Graham-Brown; Robert Preston; Warren Pickering; Gerry P McCann; James O Burton
Journal:  BMJ Open       Date:  2016-09-08       Impact factor: 2.692

Review 5.  The Diet and Haemodialysis Dyad: Three Eras, Four Open Questions and Four Paradoxes. A Narrative Review, Towards a Personalized, Patient-Centered Approach.

Authors:  Giorgina Barbara Piccoli; Maria Rita Moio; Antioco Fois; Andreea Sofronie; Lurlinys Gendrot; Gianfranca Cabiddu; Claudia D'Alessandro; Adamasco Cupisti
Journal:  Nutrients       Date:  2017-04-10       Impact factor: 5.717

6.  Left ventricular mass regression, all-cause and cardiovascular mortality in chronic kidney disease: a meta-analysis.

Authors:  Kevin C Maki; Meredith L Wilcox; Mary R Dicklin; Rahul Kakkar; Michael H Davidson
Journal:  BMC Nephrol       Date:  2022-01-16       Impact factor: 2.388

7.  Nocturnal hemodialysis.

Authors:  D Ranganathan; G T John
Journal:  Indian J Nephrol       Date:  2012-09

8.  Thrice-Weekly Nocturnal In-Centre Haemodiafiltration: A 2-Year Experience.

Authors:  Vishal Dey; Mario Hair; Beng So; Elaine M Spalding
Journal:  Nephron Extra       Date:  2015-08-29

9.  High convection volume in online post-dilution haemodiafiltration: relevance, safety and costs.

Authors:  Ira M Mostovaya; Muriel P C Grooteman; Carlo Basile; Andrew Davenport; Camiel L M de Roij van Zuijdewijn; Christoph Wanner; Menso J Nubé; Peter J Blankestijn
Journal:  Clin Kidney J       Date:  2015-06-10

10.  Protein-Bound Uremic Toxin Profiling as a Tool to Optimize Hemodialysis.

Authors:  Sunny Eloot; Daniel Schneditz; Tom Cornelis; Wim Van Biesen; Griet Glorieux; Annemie Dhondt; Jeroen Kooman; Raymond Vanholder
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.